It is known that CD40-mediated microglia activation contributes to disease progression in a variety of neuroinflammatory diseases, such as multiple sclerosis, Alzheimer’s disease, and cerebral ischemia, leading to the production of a wide array of cytokines, chemokines, matrix metalloproteinases and neurotoxins [43,44]. Here, CD40 is linked to multiple sclerosis.